SHIFTBIO

SHIFTBIO is pioneering next-generation therapeutics for CNS diseases with our proprietary dtBBB-Natural Nanoparticle (NNP) platform. This AI-driven, dual-mechanism shuttle is engineered to effectively penetrate the Blood-Brain Barrier, achieving efficient delivery of diverse payloads like ASO, siRNA, and enzymes directly into the brain parenchyma. Backed by our predictable NNP Design AI™ and cGMP-ready manufacturing, we accelerate the development of breakthrough therapies, shifting the paradigm of CNS drug delivery.

www.shiftbio.net